Related Experiment Video
Updated: Mar 19, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Biobank Regulation in South Korea
1Won Bok Lee, M.D., LL.M., S.J.D., is the Professor of Law at Ewha Law School, South Korea and executive faculty member of the Ewha Institute for Biomedical Law & Ethics (EIBLE). He received his M.D. degree from Seoul National University and LL.M. and S.J.D. degrees from Harvard Law School. The work was supported by the Ewha Womans University Research Grant of 2015.
Abstract:
Like many other countries, South Korea has recognized the importance of biobanks as a tool for medical research and has engaged in two very important tasks to foster biobanking infrastructure: funding biobanks and setting up rules to protect the integrity of biobanks that share potentially sensitive personal information.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioequivalence studies: Biowaivers
Drug Regulation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

